In this study, the cancer genome atlas (TCGA) and gene expression omnibus (GEO) datasets were used to analyze the expression of TRIM59 in tumors and evaluate the value of TRIM59 as a biomarker for tumor diagnosis and prognosis. The gene discussed is TRIM59; the disease is cancer.